- Report
- August 2024
- 141 Pages
Global
From €2747EUR$2,999USD£2,335GBP
- Report
- May 2025
- 140 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 93 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 182 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- May 2025
- 196 Pages
Global
From €5359EUR$5,850USD£4,555GBP
- Report
- January 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- March 2025
- 200 Pages
Global
From €4113EUR$4,490USD£3,496GBP
- Report
- August 2024
- 143 Pages
Global
From €2747EUR$2,999USD£2,335GBP
- Report
- January 2025
- 144 Pages
Global
From €3618EUR$3,950USD£3,075GBP
- Report
- April 2025
- 200 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1832EUR$2,000USD£1,557GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1832EUR$2,000USD£1,557GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1374EUR$1,500USD£1,168GBP
- Report
- October 2024
- 207 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- October 2024
- 237 Pages
Global
From €7283EUR$7,950USD£6,190GBP
- Report
- August 2024
- 177 Pages
Global
From €2290EUR$2,500USD£1,946GBP
- Report
- February 2025
- 186 Pages
Global
From €4122EUR$4,500USD£3,504GBP
- Report
- April 2025
- 120 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- July 2024
- 110 Pages
Global
From €4351EUR$4,750USD£3,698GBP
- Report
- December 2024
Japan, United States, ... Japan, United States, Europe, Global
From €16947EUR$18,500USD£14,403GBP

Heparin is a type of anticoagulant drug used in the treatment of cardiovascular diseases. It is a naturally occurring anticoagulant, derived from the mucous membranes of animals, and is used to prevent the formation of blood clots. It is commonly used in the treatment of deep vein thrombosis, pulmonary embolism, and atrial fibrillation. It is also used to prevent clotting during hemodialysis and to prevent clotting during surgery.
Heparin is available in both injectable and oral forms, and is typically administered in a hospital setting. It is also available in a variety of formulations, including low molecular weight heparin, unfractionated heparin, and fondaparinux. The cost of heparin varies depending on the formulation and the dosage.
Heparin is a widely used anticoagulant in the cardiovascular drugs market. It is used in a variety of cardiovascular conditions, and is an important part of the treatment of many cardiovascular diseases.
Some companies in the heparin market include Sanofi, Pfizer, Bristol-Myers Squibb, and GlaxoSmithKline. Show Less Read more